Search Results - Sorace, AG

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Abstract P6-17-33: A multi-scale mathematical model of combination targeted and cytotoxic therapy to evaluate treatment response in HER2+ breast cancer

    Abstract P6-17-33: A multi-scale mathematical model of combination targeted and cytotoxic therapy to evaluate treatment response in HER2+ breast cancer by Jarrett, AM, Shah, A, Bloom, MJ, Yankeelov, TE, Sorace, AG

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Abstract P3-05-16: A mathematical model for predicting immune response in a trastuzumab treated HER2+ breast cancer animal model: Preliminary efforts

    Abstract P3-05-16: A mathematical model for predicting immune response in a trastuzumab treated HER2+ breast cancer animal model: Preliminary efforts by Jarrett, AM, Yankeelov, TE, Ehrlich, LI, Godfrey, W, Sorace, AG

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Abstract P1-01-02: Quantitative breast MRI to predict response to neoadjuvant therapy in community imaging centers: Preliminary results

    Abstract P1-01-02: Quantitative breast MRI to predict response to neoadjuvant therapy in community imaging centers: Preliminary results by Sorace, AG, Virostko, J, Wu, C, Jarrett, AM, Barnes, SL, Ekrut, D, Patt, D, Goodgame, B, Avery, S, Yankeelov, TE

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Abstract P4-06-17: Investigating trastuzumab-induced myeloid cell alterations for improving combination therapy in HER2+ breast cancer

    Abstract P4-06-17: Investigating trastuzumab-induced myeloid cell alterations for improving combination therapy in HER2+ breast cancer by Bloom, MJ, Jarrett, AM, Triplett, TA, Syed, AK, Yankeelov, TE, Sorace, AG

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Abstract P6-01-03: Trastuzumab-induced hypoxia changes in a HER2+ murine model of breast cancer

    Abstract P6-01-03: Trastuzumab-induced hypoxia changes in a HER2+ murine model of breast cancer by Sorace, AG, Quarles, CC, Yankeelov, TE

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Abstract P4-02-02: Increased tumor perfusion following treatment with trastuzumab as measured by contrast-enhanced ultrasound

    Abstract P4-02-02: Increased tumor perfusion following treatment with trastuzumab as measured by contrast-enhanced ultrasound by Sorace, AG, Barnes, SL, Quarles, CC, McIntyre, JO, Yankeelov, TE

    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Abstract P4-12-12: Quantitative in vivo imaging of intratumoral heterogeneity to assess tumor response to trastuzumab treatment in a preclinical model of HER2+ breast cancer

    Abstract P4-12-12: Quantitative in vivo imaging of intratumoral heterogeneity to assess tumor response to trastuzumab treatment in a preclinical model of HER2+ breast cancer by Syed, A, Quarles, CC, McIntyre, JO, Barnes, SL, Yankeelov, TE, Sorace, AG

    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Abstract P4-02-08: Repeatability and reproducibility of quantitative breast MRI in community imaging centers: Preliminary results

    Abstract P4-02-08: Repeatability and reproducibility of quantitative breast MRI in community imaging centers: Preliminary results by Sorace, AG, Virostko, J, Wu, C, Jarrett, AM, Barnes, SL, Luci, J, Patt, DA, Goodgame, B, Avery, S, Yankeelov, TE

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: